Ferrous iron binding to epinephrine promotes the oxidation of iron and impedes activation of adrenergic receptors.
Autor: | Jačić JK; Department of Life Sciences, Institute for Multidisciplinary Research, University of Belgrade, 11030 Belgrade, Serbia., Nikolić L; Institute for Biological Research 'Siniša Stanković', University of Belgrade, 11000 Belgrade, Serbia., Stanković DM; Vinča Institute of Nuclear Sciences, University of Belgrade, 11000 Belgrade, Serbia., Opačić M; Department of Life Sciences, Institute for Multidisciplinary Research, University of Belgrade, 11030 Belgrade, Serbia., Dimitrijević M; Department of Life Sciences, Institute for Multidisciplinary Research, University of Belgrade, 11030 Belgrade, Serbia., Savić D; Institute for Biological Research 'Siniša Stanković', University of Belgrade, 11000 Belgrade, Serbia., Šipka SG; Faculty of Chemistry, University of Belgrade, 11000 Belgrade, Serbia., Spasojević I; Department of Life Sciences, Institute for Multidisciplinary Research, University of Belgrade, 11030 Belgrade, Serbia. Electronic address: redoxsci@gmail.com., Pristov JB; Department of Life Sciences, Institute for Multidisciplinary Research, University of Belgrade, 11030 Belgrade, Serbia. |
---|---|
Jazyk: | angličtina |
Zdroj: | Free radical biology & medicine [Free Radic Biol Med] 2020 Feb 20; Vol. 148, pp. 123-127. Date of Electronic Publication: 2020 Jan 03. |
DOI: | 10.1016/j.freeradbiomed.2020.01.001 |
Abstrakt: | Upon release in response to stress, epinephrine (Epi) may interact with labile iron pool in human plasma with potentially important (patho)physiological consequences. We have shown that Epi and Fe 3+ build stable 1:1 high-spin bidentate complex at physiological pH, and that Epi does not undergo degradation in the presence of iron. However, the interactions of Epi with the more soluble Fe 2+ , and the impact of iron on biological activity of Epi are still not known. Herein we showed that Epi and Fe 2+ build colorless complex which is stable under anaerobic conditions. In the presence of O Competing Interests: Declaration of competing interest None. (Copyright © 2020 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |